It was a quarter-century ago, but Mark Earnest, MD, PhD, still vividly recalls an “odd request” from a patient.
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045
It was a quarter-century ago, but Mark Earnest, MD, PhD, still vividly recalls an “odd request” from a patient.
Shortages of the popular injected weight-loss medicines Wegovy (semaglutide) and Zepbound (tirzepatide) aren’t going to end any time soon, according to the U.S. Food and Drug Administration (FDA).
A year ago, the federal COVID-19 Public Health Emergency officially ended, and with it came the phasing out of the Centers for Disease Control and Prevention’s authorization to collect certain types of public health data.
At her sickest, maybe on a day she puked 70 times or when walking down a hospital hallway felt like the brutal training that made her a world champion triathlete, Siri Lindley visualized running up her favorite mountain trail in Lyons.
“Better recognition and improved management of patients with the coincidence of gout and chronic kidney disease is essential to improve patient outcomes,” Richard J. Johnson, of the University of Colorado Anschutz Medical Campus, and study co-author, told Healio.
12631 East 17th Avenue
8601
Aurora, CO 80045
303-724-1785
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.